Test to skip breast surgery after chemo
Part of Cancer, Skin clinical trials.
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You have triple-negative or HER2-positive breast cancer that has not spread to lymph nodes
- You have a single tumor and no cancer elsewhere in your body
- You have finished at least 12 weeks of chemo before surgery
- Your tumor was marked with a clip before chemo started
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether it’s safe and effective to avoid removing many underarm lymph nodes in some people who, after chemotherapy, still seem to have only tiny (“micro”) cancer deposits in the sentinel lymph node. It may help reduce treatment side effects while keeping cancer control.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
This trial is testing whether some women with triple-negative breast cancer who have a complete response to chemo-immunotherapy can safely skip surgery. It is for women whose cancer completely disappeared after treatment, as shown on MRI and biopsy.
This trial tests if women with a common type of breast cancer (HR+/HER2-) can safely skip chemotherapy after surgery by taking targeted medication (ribociclib) plus hormone therapy. A special blood test called ctDNA helps doctors decide if chemo isn't needed.
This trial looks at whether some people with HER2-positive or HR-positive breast cancer can safely avoid a sentinel lymph node biopsy after chemotherapy. It tests a treatment approach based on how completely the breast tumor shrinks on MRI and whether lymph nodes look clear before treatment.
This trial tests whether it's safe to skip armpit surgery in people whose breast cancer has responded well to chemotherapy and whose lymph nodes appear cancer-free on ultrasound. It aims to reduce side effects like arm swelling while still controlling the cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.